Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Cooleys Anemia Foundation

Celgene building

Jounce bags $225m upfront in Celgene immuno-oncology deal

Five pipeline candidate agreement worth up to $2.5bn should Celgene claim the rights

- PMLiVE

The Netherlands leads Europe for future health

And benchmarking report finds UAE best placed to meet healthcare challenges

- PMLiVE

Celgene’s Revlimid cleared for aggressive lymphoma type in EU

Analysts anticipate sales of up to $10bn for the newly-expanded drug in coming years

- PMLiVE

Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

Celgene building

NICE rejects Celgene’s Vidaza for leukaemia

Final draft guidance cites ‘high degree of uncertainty’ over clinical efficacy

Celgene building

Celgene takes aim at cancer innovation with new US research consortium

Academic tie-up aims to develop new therapeutics and diagnostics

- PMLiVE

Things can only get better

How can pharma get closer to its dream scenario where patients adhere to their medicines? The answer could lay in understanding behaviours, engaging HCPs and... making medicine fun

- PMLiVE

Digitally yours: How to build effective relationships in virtual space

Can you imagine life without mobile and digital access? Certainly not. But is the healthcare sector making the most of the opportunities?

- PMLiVE

Diabetes UK uses Lego to address diabetes myths

Teams up with Brickabetes to document the highs and lows of living with diabetes

- PMLiVE

Ogilvy & Mather’s ‘Breathless choir’ wins top pharma prize at Lions Health

FCB’s ‘Project literacy’ and DAVID’s ‘Manboobs’ also take home Grand Prix awards

- PMLiVE

Apple talks up health and fitness benefits of new Watch OS

Outlines new Breathe app and stronger fitness integration for watchOS 3

- PMLiVE

EMA recruits patient voices for its management board

Continues its drive to embed patients' values within drug assessment

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links